Thiogenesis Therapeutics, Corp. is a diversified issuer with ~9% warrant dilution, 2 recent financings, and recent insider activity.
Signals on file- Warrant series
- 11
- Recent financings
- 2
- Ticker
- TTI
- Exchange
- TSXV
- Primary commodity
- diversified
- Sector
- mining
- Shares outstanding
- 51,835,956
As of 2026-06-22